PharmAust specialises in the relaunch of existing marketed products for oncology applications making the whole development, regulatory and commercialisation process much faster. In addition, PharmAust's other wholly owned subsidiary, Epichem Pty Ltd generates sales of around $1.7M per annum from contract sales to the pharmaceutical industry of synthetic drugs.
Pharmaust Limited (ASX: PAA) - Awarded NZ$715k for Specialist GMP Peptide Capabilities - Dr Nick Hagen, CEO of Mimotopes; Boardroomradio is pleased to announce that Pharmaust Limited (ASX: PAA) has published an audio file.
Pharmaust Limited (ASX: PAA) - Completion of CBI Deal and Update on AHG - Dr Paul D'Sylva, MD; Boardroomradio is pleased to announce that Pharmaust Limited (ASX: PAA) has published an audio file.
Pharmaust Limited (ASX: PAA) - Conditional Merger Proposal to Advanced Healthcare Group - Dr Paul D'Sylva, MD; Boardroomradio is pleased to announce that Pharmaust Limited (ASX: PAA) has published an audio file.
Pharmaust Limited (ASX: PAA) - Activities Update- Dr Paul D'Sylvia, MD; Boardroomradio is pleased to announce that Pharmaust Limited (ASX: PAA) has published an audio file.
Pharmaust Limited LAST WEEK'S HIGHLIGHTS<br/b>(ASX: PAA) - 2006 Full Year Results and Investor Update - Dr Paul D'Sylvia, Managing Director; Boardroomradio is pleased to announce that Pharmaust Limited (ASX: PAA) has published an audio file.
Pharmaust Limited (ASX: PAA) - 2006 Full Year Results and Investor Update - Dr Paul D'Sylvia, Managing Director; Boardroomradio is pleased to announce that Pharmaust Limited (ASX: PAA) has published an audio file.
PHARMAUST LIMITED (ASX: PAA) - Pharmaust Wins International Supply Agreement; Dr Paul D’Sylva, Managing Director; Boardroomradio is pleased to announce that PHARMAUST LIMITED (ASX: PAA) has published an audio file.
PHARMAUST LIMITED Biotech Forum<br/>The Road to Commercialisation; Boardroomradio is pleased to announce that PHARMAUST LIMITED (ASX: PAA) has published an audio file. The following presentation "" is
